en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
3/2021
vol. 123
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł przeglądowy

Mycotic corneal ulcers caused by Fusarium spp.- available therapeutic options

Ewelina Trojacka
1
,
Justyna Izdebska
1, 2
,
Marta Wroblewska
3, 4
,
Beata Sulik-Tyszka
3, 4
,
Karolina Ciepiaszuk
1, 2
,
Jacek P. Szaflik
1

1.
Independent Public Clinical Ophthalmology Hospital in Warsaw, Poland
2.
Chair and Department of Ophthalmology, II Faculty of Medicine, Medical University of Warsaw, Poland
3.
Department of Microbiology of the Central Clinical Hospital, University Clinical Center of the Medical University of Warsaw, Poland
4.
Department of Dental Microbiology, Medical University of Warsaw, Poland
KLINIKA OCZNA 2021, 123, 3: 108–113
Data publikacji online: 2021/10/13
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


Fungal corneal ulcers caused by Fusarium spp. are known as sight threatening infection with bad course.

Fungus properties, diagnostic difficulties and limited therapeutic ways result in poor outcomes.

Three of antimycotic drugs are effective against Fusarium spp.: natamycin, amphotericin B and voriconazole. Natamycin is the only drug approved by FDA (Food and Drug Administration) for treatment of corneal ulcers caused by Fusarium spp.

Fungistatic work and limited ocular penetration of antimycotic drugs lead to therapeutic keratoplasty in cases with extremely bad course. Patient with recurrent infections and very advanced inflammation, require enucleation.
facebook linkedin twitter
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.